FDA Withdraws Approval of Five New Drug Applications from Schmid Laboratories, Inc. and Others

Summary

The FDA has withdrawn approval of five new drug applications due to repeated failure to file required annual reports by the applications' holders, Schmid Laboratories, Inc. and others.